Champions Oncology (CSBR) EPS (Diluted) (QoQ) (2014 - 2026)
Champions Oncology (CSBR) EPS (Diluted) (QoQ) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Champions Oncology | 71.17 Mn | 71.17 Mn | 7.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -140.01% |
| Jan 31, 2026 | -222.56% |
| Oct 31, 2025 | 148.50% |
| Jul 31, 2025 | 73.72% |
| Apr 30, 2025 | -141.10% |
| Jan 31, 2025 | 502.49% |
| Oct 31, 2024 | -44.45% |
| Jul 31, 2024 | 1,262.14% |
| Apr 30, 2024 | 95.68% |
| Jan 31, 2024 | -21.29% |
| Oct 31, 2023 | 19.23% |
| Jul 31, 2023 | -0.45% |
| Apr 30, 2023 | -5.13% |
| Jan 31, 2023 | -15,110.02% |
| Oct 31, 2022 | 94.99% |
| Jul 31, 2022 | 2.90% |
| Apr 30, 2022 | -144.41% |
| Jan 31, 2022 | 187.32% |
| Oct 31, 2021 | 248.35% |
| Jul 31, 2021 | 72.21% |